First Time Loading...

Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 6.93 AUD -2.39% Market Closed
Updated: Apr 27, 2024

Mayne Pharma Group Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayne Pharma Group Ltd
Cash from Investing Activities Peer Comparison

Comparables:
RCE
NEU
BOT
PBP
C
CU6

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Mayne Pharma Group Ltd
ASX:MYX
Cash from Investing Activities
AU$473.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recce Pharmaceuticals Ltd
ASX:RCE
Cash from Investing Activities
-AU$530.5k
CAGR 3-Years
-122%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Cash from Investing Activities
-AU$211.5m
CAGR 3-Years
-3 179%
CAGR 5-Years
N/A
CAGR 10-Years
-171%
Botanix Pharmaceuticals Ltd
ASX:BOT
Cash from Investing Activities
-AU$16.7m
CAGR 3-Years
-902%
CAGR 5-Years
-332%
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Cash from Investing Activities
-AU$14.4m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Cash from Investing Activities
AU$3.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Mayne Pharma Group Ltd's Cash from Investing Activities?
Cash from Investing Activities
473.5m AUD

Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Cash from Investing Activities amounts to 473.5m AUD.